The fundamental distinction lies in the mechanism of action: GLP-1 agonists are receptor-specific molecules that directly stimulate GLP-1 receptors, while berberine exerts its metabolic effects primarily through AMPK activation and other pathways that do not involve direct GLP-1 receptor engagement
The GLP-1 market is not winner-take-all
GLP-1, initially designed as a drug for diabetes treatment, is now a go-to drug for weight loss
If staying at very low doses long-term worked as well, RCTs would reflect that by now
As a result, individuals taking Semaglutide often experience reduced appetite, which can lead to a decrease in calorie intake and, consequently, weight loss
Perch non ho ancora ricevuto il mio ordine